What Changes Were Made From The 2017 To The 2018 Medicare Physician Fee Schedule For Clinical Labs

Medicare is a federal health insurance program that provides coverage for individuals aged 65 and older, as well as certain younger individuals with disabilities. One component of Medicare is the Physician Fee Schedule, which establishes payment rates for services provided by physicians and other healthcare professionals. In 2018, there were several changes made to the Physician Fee Schedule that specifically impacted clinical laboratories. In this article, we will explore these changes and their implications for Healthcare Providers and patients.

Overview of the Medicare Physician Fee Schedule

The Medicare Physician Fee Schedule is updated annually by the Centers for Medicare & Medicaid Services (CMS) to reflect changes in the relative value of services provided by physicians and other healthcare professionals. The Fee Schedule is based on three key components:

  1. Resource-based relative value scale (RBRVS) - which assigns relative value units (RVUs) to each service based on the resources required to provide it.
  2. Conversion factor - which converts RVUs into payment rates.
  3. Geographic practice cost index - which adjusts payment rates based on the location where services are provided.

Providers are reimbursed based on these payment rates for services covered by Medicare. Clinical laboratories that perform Diagnostic Tests and provide other services are also reimbursed based on the Physician Fee Schedule.

Changes from the 2017 to the 2018 Medicare Physician Fee Schedule

Each year, CMS updates the Physician Fee Schedule to account for changes in medical practice, technology, and other factors that may impact the cost of providing healthcare services. In 2018, there were several significant changes made to the Fee Schedule that affected clinical laboratories:

New Payment Rates for Clinical Laboratory Tests

One of the key changes in the 2018 Physician Fee Schedule was the implementation of new payment rates for clinical laboratory tests. CMS revised the payment rates for several tests to better reflect the resources required to perform them. These changes were intended to ensure that providers are fairly compensated for the services they provide.

Changes to the Clinical Laboratory Fee Schedule

In addition to updating payment rates for individual tests, CMS also made changes to the Clinical Laboratory Fee Schedule (CLFS) in 2018. The CLFS is used to determine payment rates for clinical laboratory services based on market rates and other factors. CMS updated the CLFS to better align payment rates with the cost of providing services and to promote transparency in pricing.

Introduction of New Codes and Modifiers

Another change in the 2018 Physician Fee Schedule was the introduction of new codes and modifiers for clinical laboratory tests. These codes and modifiers are used to identify specific tests and services and to ensure that providers are reimbursed accurately for the services they provide. The addition of new codes and modifiers helps to improve coding accuracy and reduce billing errors.

Changes to Billing and Coding Guidelines

CMS also revised billing and coding guidelines for clinical laboratory services in 2018. These changes were designed to clarify the rules and requirements for submitting claims for Reimbursement and to ensure compliance with Medicare Regulations. By updating billing and coding guidelines, CMS aims to streamline the Reimbursement process and reduce administrative burden on providers.

Implications for Healthcare Providers

The changes made to the 2018 Medicare Physician Fee Schedule have several implications for Healthcare Providers, especially those who operate clinical laboratories. Some of the key implications include:

  1. Changes in Reimbursement rates for clinical laboratory tests may impact providers' revenue and profitability.
  2. Introduction of new codes and modifiers may require providers to update their billing and coding practices to ensure accurate Reimbursement.
  3. Changes to billing and coding guidelines may necessitate additional training for staff members and changes to workflows.

Overall, the changes in the Physician Fee Schedule are intended to improve transparency, accuracy, and fairness in Reimbursement for clinical laboratory services. Providers should be aware of these changes and take steps to ensure compliance with the new requirements.

Implications for Patients

Patients who rely on clinical laboratory services may also be affected by the changes in the 2018 Physician Fee Schedule. Some of the implications for patients include:

  1. Potential changes in out-of-pocket costs for laboratory tests, depending on how providers adjust their pricing in response to the new payment rates.
  2. Improved accuracy in coding and billing may result in fewer billing errors and Discrepancies, which could benefit patients by reducing confusion and incorrect charges.
  3. Changes to billing and coding guidelines may lead to faster processing of claims and reimbursements, which may improve the overall patient experience.

Patients should be aware of these changes and discuss any questions or concerns with their Healthcare Providers. It is important for patients to understand how changes in the Medicare Physician Fee Schedule may impact their access to and cost of clinical laboratory services.

Conclusion

The changes made to the 2018 Medicare Physician Fee Schedule had significant implications for clinical laboratories and the Healthcare Providers that rely on them. By updating payment rates, codes, modifiers, and billing guidelines, CMS aimed to improve transparency, accuracy, and fairness in Reimbursement for clinical laboratory services. Providers and patients should be aware of these changes and take steps to ensure compliance and understanding of the new requirements. With continued updates and revisions to the Physician Fee Schedule, it is important for Healthcare Providers and patients to stay informed and adapt to the evolving healthcare landscape.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on phlebotomy practices and healthcare. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Jessica Turner, BS, CPT

Jessica Turner is a certified phlebotomist with a Bachelor of Science in Health Sciences from the University of California, Los Angeles. With 6 years of experience in both hospital and private practice settings, Jessica has developed a deep understanding of phlebotomy techniques, patient interaction, and the importance of precision in blood collection.

She is passionate about educating others on the critical role phlebotomists play in the healthcare system and regularly writes content focused on blood collection best practices, troubleshooting common issues, and understanding the latest trends in phlebotomy equipment. Jessica aims to share practical insights and tips to help phlebotomists enhance their skills and improve patient care.

Previous
Previous

What Constitutes Medical Necessity for Molecular Testing Under Medicare

Next
Next

Advancements In Diagnostic Technology And Regulation Changes